Grey; Howard M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grey; Howard M..The latest application filed is for "inducing cellular immune responses to plasmodium falciparum using peptide and nucleic acid compositions".

Company Profile

0.13.17

Grey; Howard M. - La Jolla CA
Grey, Howard M - La Jolla CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid Compositions App 20160193316 - Sette; Alessandro ; et al.	2016-07-07
HLA binding motifs and peptides and their uses Grant 9,340,577 - Grey , et al. May 17, 2	2016-05-17
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions Grant 9,266,930 - Sette , et al. February 23, 2	2016-02-23
Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions App 20130017253 - SETTE; Alessandro ; et al.	2013-01-17
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20110097352 - Sette; Alessandro ; et al.	2011-04-28
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20090311283 - Sette; Alessandro ; et al.	2009-12-17
Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions App 20090304746 - Sette; Alessandro ; et al.	2009-12-10
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions App 20090214632 - Sette; Alessandro ; et al.	2009-08-27
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions Grant 7,572,882 - Sette , et al. August 11, 2	2009-08-11
HLA binding motifs and peptides and their uses App 20080260762 - Grey; Howard M. ; et al.	2008-10-23
Alteration of immune response using pan DR-binding peptides Grant 7,202,351 - Sette , et al. April 10, 2	2007-04-10
HLA binding motifs and peptides and their uses App 20070055049 - Grey; Howard M. ; et al.	2007-03-08
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions Grant 7,026,443 - Sette , et al. April 11, 2	2006-04-11
Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions App 20050271676 - Sette, Alessandro ; et al.	2005-12-08
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20050063983 - Sette, Alessandro ; et al.	2005-03-24
Induction of immune response against desired determinants App 20050049197 - Sette, Alessandro ; et al.	2005-03-03
CTL inducing peptides from c-erb2 (HER-2/neu) App 20040157780 - Grey, Howard M. ; et al.	2004-08-12
Subunit vaccines with a2 supermotifs App 20040157273 - Sidney, John ; et al.	2004-08-12
Subunit vaccines with A2 supermotifs App 20040096445 - Sidney, John ; et al.	2004-05-20
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions Grant 6,689,363 - Sette , et al. February 10, 2	2004-02-10
HLA-A2.1 binding peptides and their uses App 20030185822 - Grey, Howard M. ; et al.	2003-10-02
Hla Binding Peptides And Their Uses App 20020168374 - KUBO, RALPH T. ; et al.	2002-11-14
Induction of immune response against desired determinants Grant 6,413,935 - Sette , et al. July 2, 2	2002-07-02
Methods for making HLA binding peptides and their uses Grant 6,037,135 - Kubo , et al. March 14, 2	2000-03-14
Alteration of immune response using pan DR-binding peptides Grant 5,736,142 - Sette , et al. April 7, 1	1998-04-07
Immunosuppressant peptides Grant 5,679,640 - Gaeta , et al. October 21, 1	1997-10-21
Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes Grant 5,662,907 - Kubo , et al. September 2, 1	1997-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.